IGM Biosciences Net Income
| IGMSDelisted Stock | USD 1.27 0.03 2.31% |
As of the 30th of January, IGM Biosciences retains the market risk adjusted performance of (0.21), and Risk Adjusted Performance of 0.0569. IGM Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out IGM Biosciences coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if IGM Biosciences is priced fairly, providing market reflects its last-minute price of 1.27 per share. Given that IGM Biosciences is a hitting penny stock territory we urge to closely look at its total risk alpha.
IGM Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing IGM Biosciences' valuation are provided below:IGM Biosciences does not today have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. IGM |
Search Suggestions
| I | Intelsat SA | CompanyDelisted |
| IE | Ivanhoe Electric | Company |
| IMPPP | Imperial Petroleum Preferred | Company |
| IAE | Voya Asia Pacific | Fund |
| IG | Principal Exchange Traded Funds | ETF |
| IRX | CBOE 13 Week | Index |
| ID | SPACE | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, IGM Biosciences reported net income of (195.79 Million). This is 157.37% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 134.29% higher than that of the company.
IGM Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IGM Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IGM Biosciences could also be used in its relative valuation, which is a method of valuing IGM Biosciences by comparing valuation metrics of similar companies.IGM Biosciences is currently under evaluation in net income category among its peers.
IGM Fundamentals
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0289 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | 0.91 % | |||
| Current Valuation | (27.73 M) | |||
| Shares Outstanding | 36.59 M | |||
| Shares Owned By Insiders | 35.39 % | |||
| Shares Owned By Institutions | 46.88 % | |||
| Number Of Shares Shorted | 452.13 K | |||
| Price To Earning | (7.72) X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 2.68 M | |||
| Gross Profit | (5.49 M) | |||
| EBITDA | (199.47 M) | |||
| Net Income | (195.79 M) | |||
| Cash And Equivalents | 469.14 M | |||
| Cash Per Share | 10.95 X | |||
| Total Debt | 45.19 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 10.79 X | |||
| Book Value Per Share | 1.68 X | |||
| Cash Flow From Operations | (153 M) | |||
| Short Ratio | 0.38 X | |||
| Earnings Per Share | (0.90) X | |||
| Target Price | 1.12 | |||
| Number Of Employees | 16 | |||
| Beta | 0.59 | |||
| Market Capitalization | 76.57 M | |||
| Total Asset | 265.71 M | |||
| Retained Earnings | (1.02 B) | |||
| Working Capital | 155.98 M | |||
| Current Asset | 1.23 M | |||
| Current Liabilities | 3.37 M | |||
| Net Asset | 265.71 M |
About IGM Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IGM Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IGM Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IGM Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in IGM Stock
If you are still planning to invest in IGM Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IGM Biosciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |